Table 3.
COVID-19 symptoms reported during acute phase according to malnutrition status identified by GLIM criteria
| Characteristics | Whole Sample (n = 1230) |
No malnutrition (n = 959) |
Malnutrition (n = 271) |
p |
|---|---|---|---|---|
| Symptoms related to COVID-19 during acute phase | ||||
| Fatigue | 1028 (84.1) | 795 (83.3) | 233 (86.6) | 0.11 |
| Cough | 741 (60.4) | 572 (59.8) | 169 (62.4) | 0.24 |
| Short of breath | 855 (69.9) | 669 (70.2) | 186 (68.9) | 0.36 |
| Loss of appetite | 501 (41.3) | 346 (36.7) | 155 (57.8) | < 0.001 |
| Dysgeusia | 583 (47.6) | 392 (41.0) | 191 (70.7) | < 0.001 |
| Myalgia | 748 (61.2) | 569 (59.7) | 179 (66.5) | 0.02 |
| Joint pain | 704 (57.6) | 534 (56.0) | 170 (63.2) | 0.02 |
| Smell disorders | 573 (46.8) | 400 (41.9) | 173 (64.3) | < 0.001 |
| Chest pain | 463 (38.0) | 366 (38.5) | 97 (36.1) | 0.25 |
| Rhinitis | 302 (24.8) | 234 (24.6) | 68 (25.4) | 0.42 |
| Diarrhea | 387 (31.7) | 297 (31.2) | 90 (33.6) | 0.25 |
| Sore throat | 355 (29.1) | 280 (29.4) | 75 (27.9) | 0.33 |
| Headache | 622 (51.1) | 475 (49.6) | 150 (56.2) | 0.03 |
| Skin lesion | 146 (12.0) | 104 (11.0) | 42 (15.8) | 0.02 |
| Number of symptoms | 6.7 ± 3.3 | 6.5 ± 3.3 | 7.6 ± 3.0 | < 0.001 |
Data are given as means ± SD for number of symptoms; number (percent) for all the other variables are reported